...sales of NXTR's AmBisome liposomal amphotericin B were up 40 percent at $14.2 million, topping S.G. Warburg...

...Argus Pharmaceuticals Inc. (ARGS) Robert Faulkner of S.G. Warburg said the merger between ARGS, Triplex Pharmaceutical Corp...

...Regeneron Pharmaceuticals Inc. (REGN) Robert Faulkner of S.G. Warburg raised REGN to "hold" from "reduce" following the...

...Genentech Inc. S.G. Warburg analyst Kevin Wilson downgraded Genentech Inc. to "add" from "buy" on the basis...

...NeXagen Inc. (NXGN) S.G. Warburg analyst Kevin Wilson initiated coverage with a "buy" and a one-year price...

...flow to repurchase shares at the rate of $250 million per year. Kevin Wilson of S.G. Warburg...

...conducted at the University of Rochester further demonstrated the product's safety, researchers said at the S.G. Warburg...

...patients treated at doses of 3 µg/kg and above had anti-CNTF antibodies. Can't draw conclusions S.G. Warburg...